XFOR Earnings

XFOR reported its earnings on 2026-03-18, showcasing a revenue of against an estimate of 2.10M, resulting in a 0% surprise. The EPS was 0, surpassing the expected -0.36 by 0%. The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following XFOR's earnings announcement on 2026-03-18, the stock price moved by 0% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, XFOR's stock price tends to shift by an average of 10.9% in the 10 days leading up to earnings and 2.35% in the 10 days following, providing insight into potential market.

For 2025/Q2, analysts estimate XFOR's annual revenue to reach 1.90M, while the EPS is projected at -4.29. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between XFOR's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, XFOR's stock price typically moves by 10.9% in the 10 days before its earnings and 2.35% in the 10 days after. For the upcoming 2025/Q2 earnings, analysts expect an EPS of -4.29 and revenue of 1.90M.

The earnings call presents a mixed picture. Financially, the company is stable with $90 million in cash and a strategic spending reduction plan. However, sales are modest, and there are concerns about supply chain challenges and competitive pressures. The reverse stock split and lack of clear guidance on patient dropout rates in trials could raise investor caution. The Q&A revealed strong demand and patient compliance, but management's vague responses on certain metrics may worry analysts. Overall, the sentiment is balanced, leading to a neutral prediction for stock movement.